Olaptesed pegol (sodium)
Olaptesed pegol sodium A pegylated-based L-oligoribonucleotide aptamer targeting CXCL12. Olaptesed pegol sodium neutralizes CXCL12, and CXCL12 inhibition mobilizes chronic lymphocytic leukemia cells into the circulation and prevents their homing into the protective microenvironment[1].
Product Specifications
UNSPSC
12352208
Target
CXCR
Type
Oligonucleotides
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/olaptesed-pegol-sodium.html
Purity
95.94
Solubility
10 mM in DMSO
Smiles
[Olaptesedpegol(sodium)]
References & Citations
[1]Steurer M, Montillo M, Scarfò L, Mauro FR, Andel J, Wildner S, Trentin L, Janssens A, Burgstaller S, Frömming A, Dümmler T, Riecke K, Baumann M, Beyer D, Vauléon S, Ghia P, Foà R, Caligaris-Cappio F, Gobbi M. Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia. Haematologica. 2019 Oct;104 (10) :2053-2060.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2148-100 1x 100 µL
Cytokeratin, Basic (Type II or HMW) (rKRTH/2148), 0.2mg/mL
Sign In for Pricing
View Details 
BNC043340-100 1x 100 µL
CD11b / MAC-1 (Microglial Marker) (ITGAM/3340), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details